UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

(Mark One)

      |X|   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
            EXCHANGE ACT OF 1934

                  For the quarterly period ended July 31, 2006

                                       or

      |_|   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
            EXCHANGE ACT

          For the transition period from _____________ to _____________

                        Commission File Number 001-31756

                                   Argan, Inc.
        (Exact Name of Small Business Issuer as Specified in Its Charter)

            Delaware                                              13-1947195
(State or other Jurisdiction of                                (I.R.S. Employer
 Incorporation or Organization)                              Identification No.)

                One Church Street, Suite 401, Rockville MD 20850
                    (Address of Principal Executive Offices)

                                 (301) 315-0027
                (Issuer's Telephone Number, Including Area Code)

                                       N/A
              (Former Name, Former Address and Former Fiscal Year,
                          if Changed Since Last Report)

      Check whether the issuer (1) filed all reports required to be filed by
Section 13 or 15 (d) of the Exchange Act during the past twelve months (or for
such shorter period that the Registrant was required to file such reports), and
(2) has been subject to such filing requirements for the past 90 days.

      Yes |X| No |_|

      Indicate by check mark whether the Registrant is a shell company (as
defined in Rule 12b-2) of the Exchange Act). Yes |_| No |X|

Common Stock, par value $.15 per share, outstanding at September 7, 2006:
4,574,010.

Transitional Small Business Disclosure Format (Check One): Yes |_| No |X|

<PAGE>

                                   ARGAN, INC.

                                      INDEX

                                                                        Page No.
                                                                        --------
PART I. FINANCIAL INFORMATION .......................................       3
Item 1. Financial Statements (unaudited) ............................       3
Condensed Consolidated Balance Sheets - July 31, 2006 and
  January 31, 2006 ..................................................       3
Condensed Consolidated Statements of Operations for the Three and
  Six Months Ended July 31, 2006 and 2005 ...........................       4
Condensed Consolidated Statements of Cash Flows for the Six Months
  Ended July 31, 2006 and 2005 ......................................       5
Notes to Condensed Consolidated Financial Statements ................       6
Item 2. Management's Discussion and Analysis or Plan of Operation ...      18
Item 3. Controls and Procedures .....................................      32
PART II. OTHER INFORMATION ..........................................      32
Item 1. Legal Proceedings ...........................................      32
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds..      32
Item 3. Defaults Upon Senior Securities .............................      32
Item 4. Submission of Matters to a Vote of Security Holders .........      32
Item 5. Other Information ...........................................      32
Item 6. Exhibits ....................................................      33
SIGNATURES ..........................................................      34


                                        2

<PAGE>

PART . FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS

                                   ARGAN, INC.
                      Condensed Consolidated Balance Sheets
                                   (Unaudited)

<TABLE>
<CAPTION>
                                                                             July 31,      January 31,
                                                                               2006           2006
                                                                           ------------   ------------
<S>                                                                        <C>            <C>
ASSETS
CURRENT ASSETS:
  Cash and cash equivalents                                                $    161,000   $      5,000
  Accounts receivable, net of allowance for doubtful accounts of $70,000
    at 7/31/2006 and $50,000 at 1/31/2006                                     3,888,000      3,351,000
  Receivable from affiliated entity                                             148,000        157,000
  Escrowed cash                                                                 300,000        300,000
  Estimated earnings in excess of billings                                      581,000        675,000
  Inventories, net of reserves of $95,000 at 7/31/2006 and 1/31/06            2,867,000      3,410,000
  Prepaid expenses and other current assets                                     782,000        458,000
                                                                           ------------   ------------
TOTAL CURRENT ASSETS                                                          8,727,000      8,356,000
Property and equipment, net of accumulated depreciation of
  $1,878,000 at 7/31/2006 and $1,418,000 at 1/31/2006                         3,418,000      3,324,000
Issuance cost for subordinated debt                                                  --        257,000
Other assets                                                                     36,000         46,000
Contractual customer relationships, net                                       1,643,000      1,894,000
Trade name                                                                      224,000        224,000
Proprietary formulas, net                                                       497,000        726,000
Non-compete agreement, net                                                    1,110,000      1,290,000
Goodwill                                                                      7,505,000      7,505,000
                                                                           ------------   ------------
TOTAL ASSETS                                                               $ 23,160,000   $ 23,622,000
                                                                           ============   ============
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
  Accounts payable                                                         $  2,962,000   $  3,205,000
  Due to affiliates                                                              13,000        121,000
  Accrued expenses                                                            2,288,000      1,801,000
  Billings in excess of cost and earnings                                         7,000             --
  Deferred income tax liability                                                      --         49,000
  Line of credit                                                              1,343,000      1,243,000
  Current portion of long-term debt                                             113,000        421,000
                                                                           ------------   ------------
TOTAL CURRENT LIABILITIES                                                     6,726,000      6,840,000
Deferred income tax liability                                                 1,421,000      1,618,000
Deferred rent                                                                    13,000         10,000
Long-term debt                                                                  132,000        176,000
Subordinated note due former owner of Vitarich Laboratories, Inc.             1,492,000      3,292,000
                                                                           ------------   ------------
TOTAL LIABILITIES                                                             9,784,000     11,936,000
                                                                           ------------   ------------
STOCKHOLDERS' EQUITY
  Preferred stock, par value $.10 per share - 500,000 shares authorized-
    issued  - none                                                                   --             --
  Common stock, par value $.15 per share -
    12,000,000 shares authorized -  4,577,243 and 3,817,243 shares
    issued at 7/31/2006 and 1/31/2006 and  4,574,010 and 3,814,010
    Shares outstanding at 7/31/2006 and 1/31/2006                               686,000        572,000
  Warrants outstanding                                                          849,000        849,000
  Additional paid-in capital                                                 27,085,000     25,336,000
  Accumulated deficit                                                       (15,211,000)   (15,038,000)
  Treasury stock at cost: - 3,233 shares at 7/31/2006 and 1/31/2006             (33,000)       (33,000)
                                                                           ------------   ------------
TOTAL STOCKHOLDERS' EQUITY                                                   13,376,000     11,686,000
                                                                           ------------   ------------
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY                                 $ 23,160,000   $ 23,622,000
                                                                           ============   ============
</TABLE>

                               See Accompany Notes


                                        3

<PAGE>

                                   ARGAN, INC.
                 Condensed Consolidated Statements of Operations
                                   (Unaudited)

<TABLE>
<CAPTION>
                                       Three months ended July 31,   Six months ended July 31,
                                       ---------------------------   -------------------------
                                          2006            2005           2006          2005
                                       -----------   -------------   -----------   -----------
<S>                                    <C>            <C>            <C>           <C>
Net sales
  Nutraceutical products               $5,211,000     $ 4,524,000    $11,040,000   $ 9,252,000
  Telecom infrastructure services       3,349,000       2,328,000      6,482,000     4,756,000
                                       ----------     -----------    -----------   -----------
Net sales                               8,560,000       6,852,000     17,522,000    14,008,000
Cost of sales
  Nutraceutical products                3,940,000       3,559,000      8,326,000     6,989,000
  Telecom infrastructure services       2,678,000       1,932,000      5,001,000     3,839,000
                                       ----------     -----------    -----------   -----------
Gross profit                            1,942,000       1,361,000      4,195,000     3,180,000
Selling, general and administrative
  expenses                              1,944,000       1,986,000      3,920,000     3,826,000
                                       ----------     -----------    -----------   -----------
  (Loss) income from operations            (2,000)       (625,000)       275,000      (646,000)
Interest expense and amortization of
  subordinated debt issuance costs        216,000         103,000        477,000       159,000
Other (income) expense, net                (1,000)      1,952,000         (3,000)    1,925,000
                                       ----------     -----------    -----------   -----------
  Loss from operations before
    income taxes                         (217,000)     (2,680,000)      (199,000)   (2,730,000)
Income tax benefit                         62,000         294,000         26,000       322,000
                                       ----------     -----------    -----------   -----------
Net loss                               $ (155,000)    $(2,386,000)   $  (173,000)  $(2,408,000)
                                       ==========     ===========    ===========   ===========
Basic and diluted loss per share       $    (0.03)    $     (0.76)   $     (0.04)  $     (0.79)
                                       ==========     ===========    ===========   ===========
Weighted average number of shares
  outstanding - basic and diluted       4,549,000       3,136,000      4,181,000     3,064,000
                                       ==========     ===========    ===========   ===========
</TABLE>

                               See Accompany Notes


                                        4

<PAGE>

                                   ARGAN, INC.
                 Condensed Consolidated Statements of Cash Flows
                                   (unaudited)

<TABLE>
<CAPTION>
                                                                           Six Months Ended
                                                                               July 31,
                                                                      -------------------------
                                                                          2006          2005
                                                                      -----------   -----------
<S>                                                                   <C>           <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss                                                              $  (173,000)  $(2,408,000)
Adjustments to reconcile net  loss to net cash provided by
  operating activities:
    Depreciation                                                          518,000       390,000
    Amortization of debt issuance costs                                   257,000        32,000
    Amortization of purchase intangibles                                  660,000       848,000
    Deferred income taxes                                                (246,000)     (322,000)
    Non-cash loss on liability for derivative financial instruments            --     1,930,000
    Gain on sale of property and equipment                                  8,000            --
    Non-cash stock option compensation expense                             80,000            --
Changes in operating assets and liabilities:
    Accounts receivable, net                                             (537,000)     (456,000)
    Receivable from affiliated entity                                       9,000       (18,000)
    Estimated earnings in excess of billings                               94,000      (128,000)
    Inventories, net                                                      543,000       811,000
    Prepaid expenses and other current assets                            (337,000)      (39,000)
    Accounts payable and accrued expenses                                 164,000        33,000
    Billings in excess of estimated earnings                                7,000            --
    Due to affiliates                                                    (108,000)       69,000
    Other                                                                  14,000        12,000
                                                                      -----------   -----------
      Net cash provided by operating activities                           953,000       754,000
                                                                      -----------   -----------
CASH FLOWS FROM INVESTING ACTIVITIES:
    Purchases of property and equipment                                  (612,000)     (793,000)
    Purchase of Vitarich Laboratories, Inc.                                    --      (270,000)
    Proceeds from sale of property and equipment                            4,000            --
                                                                      -----------   -----------
      Net cash used in investing activities                              (608,000)   (1,063,000)
                                                                      -----------   -----------
CASH FLOWS FROM FINANCING ACTIVITIES:
    Proceeds from escrow cash                                                  --       304,000
    Net proceeds from sale of stock                                     1,863,000            --
    Proceeds from line of credit                                        2,855,000     1,500,000
    Proceeds from long-term debt                                               --         8,000
    Payments on line of credit                                         (2,755,000)   (1,148,000)
    Principal payments on long-term debt                                 (352,000)     (398,000)
    Principal payments on subordinated note due former owner of
    Vitarich Laboratories, Inc.                                        (1,800,000)           --
                                                                      -----------   -----------
      Net cash (used in) provided by  financing activities               (189,000)      266,000
                                                                      -----------   -----------
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS                      156,000       (43,000)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD                            5,000       167,000
                                                                      -----------   -----------
CASH AND CASH EQUIVALENTS AT END OF PERIOD                            $   161,000   $   124,000
                                                                      ===========   ===========
</TABLE>

                               See Accompany Notes


                                        5

<PAGE>

                                   ARGAN, INC.
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                   (Unaudited)

NOTE 1- ORGANIZATION

NATURE OF OPERATIONS

Argan, Inc. ("AI" or the "Company") conducts its operations through its wholly
owned subsidiaries Vitarich Laboratories, Inc. ("VLI") which it acquired in
August 2004 and Southern Maryland Cable, Inc. ("SMC") which it acquired in July
2003. Through VLI, the Company develops, manufactures and distributes premium
nutritional supplements, whole-food dietary supplements and personal care
products. Through SMC, the Company provides telecommunications infrastructure
services including project management, construction and maintenance to the
Federal Government, telecommunications and broadband service providers, as well
as electric utilities primarily in the Mid-Atlantic region.

AI operates in two reportable segments. (See Note 9)

MANAGEMENT'S PLANS, LIQUIDITY AND BUSINESS RISKS

As of July 31, 2006, the Company had an accumulated deficit of approximately $15
million. At July 31, 2006, the Company had approximately $2.9 million available
under its revolving line of credit with the Bank of America, N.A. (the Bank).
The Company operates in two distinct and separate reportable segments. The
market for nutritional products is highly competitive and the telecom and
infrastructure services industry is fragmented, but also very competitive. The
successful execution of the Company's business plan is dependent upon the
Company's ability to integrate acquired businesses and their related assets into
its operations, its ability to increase and retain its customers, the ability to
maintain compliance with significant government regulation, the ability to
attract and retain key employees and the Company's ability to manage its growth
and expansion, among other factors.

On May 4, 2006, the Company completed a private offering of 760,000 shares of
common stock at a price of $2.50 per share for aggregate proceeds of $1.9
million. The Company used $1.8 million of the proceeds to pay down an equal
notional amount of the subordinated note due the former owner of VLI. The
remainder of the proceeds were used for general corporate purposes. One of the
investors, MSRI SBIC, L.P., which acquired 240,000 shares in the offering, is
controlled by Daniel Levinson, a director of the Company. In addition, James
Quinn, a director of the Company acquired 40,000 shares for his own account.
(See Notes 5 and 7)

On May 5, 2006, the Company renewed its line of credit with the Bank, extending
the maturity date to May 31, 2007. Concurrent with the renewal, the Bank has
agreed to provide a new $1.5 million term loan facility (New Term Loan) designed
to refinance the subordinated note with the former owner of VLI that had an
outstanding balance of $1,492,000 at July 31, 2006. The Company must be in
compliance with its debt covenants to draw on the New Term Loan. (See Note 6)

The financing arrangement with the Bank requires the Company to comply with
certain financial covenants. At January 31, 2006, the Company failed to comply
with financial covenants requiring that the ratio of debt to pro forma earnings
before interest, taxes, depreciation and amortization not exceed 2.5 to 1 and
requiring a pro forma fixed charge coverage ratio of not less than 1.25 to 1.
The Bank waived the failure for the measurement period ended January 31, 2006.
For future measurement periods, the Bank revised the definitions of certain
components of the financial covenants to specifically exclude the impact of
VLI's impairment loss at January 31, 2006.


                                        6

<PAGE>

The subordinated debt due the former owner of VLI was originally due on August
1, 2006. On May 5, 2006, the Company entered into an agreement with the former
owner of VLI to delay the timing of the payment on the subordinated debt to
August 1, 2007. On August 31, 2006, the Company borrowed $1.5 million under the
New Term Loan and paid the remaining principal and interest due on the
subordinated note with Thomas. (See Note 6)

Management believes that capital resources available under its renewed line of
credit combined with cash generated from the Company's operations is adequate to
meet the Company's future operating cash needs. Accordingly, the carrying value
of the assets and liabilities in the accompanying balance sheet do not reflect
any adjustments should the Company be unable to meet its future operating cash
needs in the ordinary course of business. The Company continues to take various
actions to align its cost structure to appropriately match its expected
revenues, including limiting its operating expenditures and controlling its
capital expenditures. Any future acquisitions, other significant unplanned costs
or cash requirements may require the Company to raise additional funds through
the issuance of debt and equity securities. There can be no assurance that such
financing will be available on terms acceptable to the Company, or at all. If
additional funds are raised by issuing equity securities, significant dilution
to the existing stockholders may result.

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation - The condensed consolidated balance sheet as of July 31,
2006, the condensed consolidated statements of operations for the three and six
months ended July 31, 2006 and 2005, and the statements of cash flows for the
six month period ended July 31, 2006 and 2005, are unaudited. In the opinion of
management, the accompanying financial statements contain all adjustments, which
are of a normal and recurring nature, considered necessary to present fairly the
financial position of the Company as of July 31, 2006 and the results of its
operations and its cash flows for the interim periods presented. The Company
prepares its interim financial information using the same accounting principles
as it does for its annual financial statements.

These financial statements do not include all disclosures associated with annual
financial statements and, accordingly, should be read in conjunction with the
footnotes contained in the Company's consolidated financial statements for the
year ended January 31, 2006, together with the independent registered public
accounting firm's report, included in the Company's Annual Report on Form
10-KSB, as filed with the Securities and Exchange Commission (SEC). The results
of operations for any interim period are not necessarily indicative of the
results of operations for any other interim period or for a full fiscal year.

Reclassifications - Certain amounts in the prior year financial statements have
been reclassified to conform with the presentation in the current year financial
statements.

Inventories - Inventories are stated at the lower of cost or market (net
realizable value). Cost is determined on the first-in, first-out (FIFO) method.
Appropriate consideration is given to obsolescence, excessive inventory levels,
product deterioration, and other factors in evaluating net realizable value.

Inventories consist of the following:

                   July 31, 2006   January 31, 2006
                   -------------   ----------------
Raw materials       $2,544,000        $3,190,000
Work-in process        314,000            70,000
Finished goods         104,000           245,000
Less:  Reserves        (95,000)          (95,000)
                    ----------        ----------
Inventories, net    $2,867,000        $3,410,000
                    ==========        ==========


                                        7

<PAGE>

The Company entered into an agreement with one of its major customers, whereby
the customer made an advanced payment to the Company for a significant portion
of raw material at cost. The raw material is held at the Company's premises and
is used in the production of a product for the customer. The Company is
accounting for this as an inventory financing arrangement and recognizes revenue
from the sale of the raw material when the finished product is shipped to the
customer. At July 31, 2006, the Company had customer deposits and inventories
related to this arrangement of $466,000.

Earnings Per Share - Income per share is computed by dividing net loss by the
weighted average number of common shares outstanding for the period. Dilutive
earnings per share represent net income divided by the weighted average number
of common shares outstanding inclusive of the effects of dilutive securities.
Outstanding stock options and warrants for the purchase of 5,000 shares of
common stock were not included in the weighted average shares outstanding during
the three and six months ended July 31, 2006, because they are antidilutive.

Seasonality - The Company's telecom infrastructure services operations are
expected to have seasonally weaker results in the first and fourth quarters of
our year, and may produce stronger results in the second and third quarters.
This seasonality is primarily due to the effect of winter weather on outside
plant activities as well as reduced daylight hours and customer budgetary
constraints. Certain customers tend to complete budgeted capital expenditures
before the end of the year, and postpone additional expenditures until the
subsequent fiscal period.

Stock Option Plans - Prior to February 1, 2006, the Company measured
compensation costs for stock based compensation plans using the intrinsic value
method of accounting as prescribed in Accounting Principles Board Opinion No. 25
"Accounting for Stock Issued to Employees" ("APB No. 25") and related
interpretations. In electing to follow APB No. 25 for expense recognition
purposes for the three and six months ended July 31, 2005, the Company has
provided below the expanded disclosures required under Statement of Financial
Accounting Standards No. 148 "Accounting for Stock Based Compensation" ("SFAS
No. 148") for stock-based compensation granted including, if materially
different from reported results, disclosure of pro forma net income and net
income per share had compensation expense relating to grants been measured under
the fair value recognition provisions of SFAS No. 123, "Accounting for
Stock-Based Compensation" ("SFAS No. 123"). All options issued and outstanding
at July 31, 2005 had an exercise price greater than the market price of the
Company's stock on the date of grant. The fair values of options granted have
been estimated at the date of grant using a Black-Scholes option-pricing model.
Option valuation models require the use of subjective assumptions and changes in
these assumptions can materially impact the fair value of the options.

The following table illustrates the effect on net loss and net loss per share if
the Company had applied the fair value recognition provisions of SFAS No. 123 to
options granted and unvested under the Plan for the three and six months ended
July 31, 2005. For purposes of this pro forma disclosure, the value of options
is estimated using a Black-Scholes option-pricing formula and amortized over the
options' vesting periods.


                                        8

<PAGE>

                              Pro Forma Disclosures

                                       Six months      Three months
                                     ended July 31,   ended July 31,
                                          2005             2005
                                     --------------   --------------
Net loss, as reported                 $(2,408,000)     $(2,386,000)
Deduct: Total stock-based employee
  compensation expense determined
  under fair value based methods           43,000           23,000
                                      -----------      -----------
Pro forma net loss                    $(2,451,000)     $(2,409,000)
                                      ===========      ===========
Basic and diluted per share:
Basic and diluted - as reported       $     (0.79)     $     (0.76)
                                      ===========      ===========
Basic and diluted - pro forma         $     (0.80)     $     (0.77)
                                      ===========      ===========

Impact of Changes in Accounting Standards

In July 2006, the Financial Accounting Standards Board (FASB) issued FASB
Interpretation No. 48, Accounting for Uncertainty in Income Taxes - an
interpretation of FASB Statement No. 109 ("FIN 48"), which clarifies the
accounting for uncertainty in income tax positions. FIN 48 requires that the
Company recognize in the consolidated financial statements the impact of a tax
position that is more likely than not to be sustained upon examination based on
the technical merits of the position. The provisions of FIN 48 will be effective
for the Company, as of the beginning of the Company's fiscal year ending January
31, 2008, with the cumulative effect of the change in accounting principle
recorded as an adjustment to opening retained earnings. The Company is currently
evaluating the impact of adopting FIN 48 on the consolidated financial
statements.

NOTE 3 - STOCK BASED COMPENSATION

At July 31, 2006, the Company has a stock option plan which was established in
August 2001 (Plan). Under the Plan, the Company's Board of Directors may grant
stock options to officers, directors and key employees. The Plan was amended in
April 2003 to authorize the grant of options for up to 250,000 shares of common
stock.

Prior to February 1, 2006, the Company accounted for the Plan under the
recognition and measurement provisions of Accounting Principles Board Opinion
No. 25 "Accounting for Stock Issued to Employees ("APB No. 25"), and related
interpretations, as permitted by Statements of Financial Accounting Standards
("SFAS") No. 123, "Accounting for Stock Based Compensation ("SFAS No. 123"). No
stock-based employee compensation cost was recognized in the Statement of
Operations for the three and six months ended July 31, 2005, as all options
granted under the Plan had an exercise price equal to or greater than the market
value of the underlying common stock on the date of grant. Effective February 1,
2006, the Company adopted the fair value recognition provisions of SFAS No.
123(R), "Share-Based Payment" (SFAS No. 123(R)), using the modified-prospective
transition method. Under that transition method, compensation cost recognized in
the six months ended July 31, 2006 includes: (a) compensation cost for all
share-based payments granted prior to, but not yet vested as of February 1,
2006, based on grant date fair value estimated in accordance with the original
provisions of SFAS No. 123 and (b) compensation cost for all share-based
payments granted on or subsequent to February 1, 2006, based on the grant-date
fair value estimated in accordance with the provisions of SFAS No. 123(R).
Results for prior periods have not been restated.

As a result of adopting SFAS No. 123(R) on February 1, 2006, the Company's loss
before income taxes for the six and three months ended July 31, 2006, was
approximately $80,000 and $69,000, respectively, more than if it had continued
to account for share based compensation under APB No. 25. Basic and diluted loss
per share for the six and three months ended July 31, 2006 would have been $0.02
more than if it had continued to account for share based compensation under APB
No. 25.


                                        9

<PAGE>

Stock options granted may be "Incentive Stock Options" ("ISOs") or "Nonqualified
Stock Options" (NSOs"). ISOs have an exercise price at least equal to the
stock's fair market value at the date of grant, a ten-year term and vest and
become fully exercisable one year from the date of grant. NSOs may be granted at
an exercise price other than the stock's fair market value at the date of grant
and have up to a ten-year term, and vest and become fully exercisable as
determined by the Board.

The fair value of each option award is estimated on the date of grant using a
Black-Scholes option-pricing formula that uses the assumptions noted in the
table and discussion that follows:

                          Six Months Ended July 31,
                          -------------------------
                                2006     2005
                               -----    -----
Dividend yield                   --       --
Expected volatility              57%      56%
Risk-free interest rate        5.11%    4.16%
Expected life in years            5        5

A summary of option activity under the Plan as of July 31, 2006, and changes in
the six months then ended is presented below:

<TABLE>
<CAPTION>
                                                 Weighted-     Weighted-
                                                  Average       Average      Aggregate
                                                  Exercise     Remaining     Intrinsic
               Options                  Shares     Price     Contract Term     Value
------------------------------------   -------   ---------   -------------   ---------
<S>                                    <C>         <C>            <C>         <C>
Outstanding at beginning of period      73,000     $7.84
Granted                                160,000     $2.49
Exercised                                   --
Forfeited or expired                    (3,000)    $7.76
                                       -------
Outstanding at end of period           230,000     $4.12          8.6         $423,000
                                       =======
Vested or expected to vest at end of
  period                               230,000     $4.12          8.6         $423,000
Exercisable at end of period            62,200     $7.85          6.0         $200,000
</TABLE>

The weighted average grant date fair value of options granted during the six
months ended July 31, 2006 and 2005 was $1.34 and $2.78, respectively.

No options were exercised during the six months ended July 31, 2006 and 2005. At
July 31, 2006, there was $149,000 of total unrecognized compensation cost
related to stock options granted under the Plan. That cost is expected to be
recognized over the next six months which represents the six month vesting
period of options granted. The total fair value of shares vested during the six
months ended July 31, 2006 and 2005, was $62,000 and $19,000, respectively.

A summary of the status of the Company's nonvested shares as of July 31, 2006,
and changes during the six months then ended, is present below:

                                             Aggregate
                                             Intrinsic
                                    Shares     Value
                                   -------   ---------
Nonvested at beginning of period    16,000     $1.95
Granted                            160,000     $1.34
Vested                              (8,000)    $2.78
Forfeited                           (3,000)    $2.25
                                   -------
Nonvested at end of period         165,000     $1.33
                                   =======


                                       10

<PAGE>

The fair value of nonvested shares is determined based on the opening trading
price of the Company's shares on the grant date.

In connection with the Company's private placement in April 2003, the Company
issued warrants to purchase shares of the Company's common stock at a price of
$7.75 per share with a ten year term. 180,000 of the warrants were granted to
three individuals who became the executive officers of the Company upon
completion of the offering. In addition, MSR Advisors, Inc. (MSR) received
warrants to purchase 50,000 shares of the Company's stock. A director of the
Company is the Chief Executive Officer of MSR. The fair value of the warrants of
$849,000 was recognized as offering costs. All warrants are exercisable.

At July 31, 2006, there were 460,000 shares of the Company's common stock
reserved for issuance upon exercise of stock options and warrants.

NOTE 4- SUMMARY OF INTANGIBLE ASSETS

The Company's intangible assets consist of the following at July 31, 2006.

<TABLE>
<CAPTION>
                                                                    SMC            VLI
                   Estimated    Gross Carrying    Accumulated   Impairment     Impairment     Net Carrying
                  Useful Life       Amount       Amortization     Loss(1)        Loss(2)         Amount
                  -----------   --------------   ------------   ----------     ----------     ------------
<S>               <C>           <C>               <C>           <C>            <C>            <C>
Goodwill          Indefinite    $14,055,000(3)    $       --    $  740,000(1)  $5,810,000(2)  $ 7,505,000
Contractual
  Customer
  Relationships   5-7 years       3,600,000        1,211,000       746,000(1)          --       1,643,000
Proprietary
  Formulas        3 years         2,500,000        1,316,000            --        687,000(2)      497,000
Non-Compete
  Agreement       5 years         1,800,000          690,000            --             --       1,110,000
Trade Name        Indefinite        680,000               --       456,000(1)          --         224,000
                                -----------       ----------    ----------     ----------     -----------
                                $22,635,000       $3,217,000    $1,942,000(1)  $6,497,000(2)  $10,979,000
                                ===========       ==========    ==========     ==========     ===========
</TABLE>

(1) During the twelve months ended January 31, 2005, the Company recorded an
impairment loss with respect to goodwill and intangibles at SMC.

(2) During the twelve months ended January 31, 2006, the Company recorded an
impairment loss with respect to goodwill and proprietary formulas at VLI.

(3) Amounts recorded as goodwill are not deductible for tax reporting purposes.

Amortization expense for the six months ended July 31, 2006, aggregated
$251,000, $229,000 and $180,000 for Contractual Customer Relationships,
Proprietary Formulas and Non-Compete Agreement, respectively. Amortization
expense for the six months ended July 31, 2005, aggregated $231,000, $417,000
and $200,000 for Contractual Customer Relationships, Proprietary Formulas and
Non-Compete Agreement, respectively.

NOTE 5 - RELATED PARTY TRANSACTIONS

On May 4, 2006, the Company completed a private offering of 760,000 shares of
common stock at a price of $2.50 per share for aggregate proceeds of $1.9
million. These shares were registered with the SEC effective July 10, 2006. The
Company used $1.8 million of the proceeds to pay down an equal notional amount
of the subordinated note due Kevin Thomas ("Thomas").The remainder of the
proceeds were used for general corporate purposes.


                                       11

<PAGE>

One of the investors, MSRI SBIC, L.P., which acquired 240,000 shares in the
offering, is controlled by Daniel Levinson, a director of the Company. In
addition, James Quinn, a director of the Company acquired 40,000 shares for his
own account.

On January 28, 2005, the Company sold and issued to MSR I SBIC, L.P., a Delaware
limited partnership ("Investor"), 129,032 shares of common stock of the Company
pursuant to a Subscription Agreement between the Company and Investor
("Subscription Agreement"). These Shares were issued at a purchase price of
$7.75 per share, yielding aggregate proceeds of $999,998. (See Note 7) These
Shares were issued pursuant to the exemption provided by Section 4(2) of the
Securities Act of 1933, as amended. The Investor is an entity controlled by
Daniel Levinson, a director of the Company.

Pursuant to the Subscription Agreement, the Company agreed to issue additional
shares of the Company's common stock to Investor in accordance with the
Subscription Agreement under certain conditions upon the earlier of (i) the
Company's issuance of additional shares of common stock having an aggregate
purchase price of at least $2,500,000, at a price per share less than $7.75
subject to certain exclusions, or (ii) ninety percent of the average bid price
of the Company's common stock for the thirty days ended July 31, 2005 if the
price was less than $7.75, less the 129,032 shares previously issued. The
Company settled the liability for issuance of additional shares in a non-cash
transaction at July 31, 2005 with the issuance of 95,321 shares of the Company's
common stock.

The provision in the Subscription Agreement which allows the Investor to receive
additional shares under certain conditions represents a derivative under
Statement of Financial Accounting Standards No. 133 "Accounting for Derivative
Instruments and Hedging Activities." Accordingly, $139,000 of the proceeds
received at issuance was accounted for as a liability for a derivative financial
instrument. This liability relates to the obligation to issue Investor
additional shares under certain conditions. The derivative financial instrument
was subject to adjustment for changes in fair value subsequent to issuance.
During the three and six months ended July 31, 2005, the Company recorded a fair
value loss adjustment of $344,000 and $343,000, respectively, which is recorded
in other expense (income), net.

On January 31, 2005, the Company entered into a debt subordination agreement
with Thomas, the former owner of VLI, for the cash portion of the additional
consideration the Company owes Thomas. The subordinated debt had an original
maturity of August 1, 2006 and had an interest rate of 10%. On May 5, 2006, the
Company entered into an extension with Thomas of the maturity date of the
subordinated note to August 1, 2007. The remaining principal and interest due on
this note was paid on August 31, 2006.

At issuance, $501,000 of the charge related to the liability for derivative
financial instruments was recorded as deferred issuance cost for subordinated
debt which will be amortized over the life of the subordinated debt. The
amortization of the deferred loan issuance cost increases the Company's interest
expense through August 1, 2007, the maturity date of the note, and reduces net
income. The derivative financial instrument was subject to adjustment for
changes in fair value subsequent to issuance. The fair value adjustment of a
$1,609,000 and $1,587,000 gain during the six and three months ended July 31,
2005, respectively, was reflected as a change in liability for the derivative
financial instruments and as a credit to the Company's other expense (income),
net. The liability for the derivative financial instrument was settled as a
non-cash transaction by the issuance of 535,052 shares of the Company's common
stock on September 1, 2005.

The Company leases administrative, manufacturing and warehouse facilities for
various lengths of time from individuals who are officers of SMC and VLI. The
total expense under these arrangements was $64,000 and $140,000 for the three
and six months ended July 31, 2006, respectively, and $78,000 and $147,000 for
the three and six months ended July 31, 2005, respectively.

The Company has also entered into a supply agreement with an entity owned by the
former shareholder of VLI whereby the supplier committed to sell to the Company
and the Company committed to purchase on an as-needed basis, certain organic
products. VLI made $38,000 and $55,000 in purchases under the supply agreement
during the three and six months ended July 31, 2006, respectively, and $55,000
and $79,000 for the three and six months ended July 31, 2005, respectively.

The Company also sells its products in the normal course of business to an
entity in which the former owner of VLI has an ownership interest. VLI had
approximately $157,000 and $286,000 in sales with this entity for three and six
months ended July 31, 2006, respectively, and $152,000 and $301,000 for the
three and six months ended July 31, 2005, respectively. At July 31, 2006 and
January 31, 2006, the affiliated entity owed $148,000 to VLI.


                                       12

<PAGE>

NOTE 6 - DEBT

In May 2006, the Company agreed to amend the existing financing arrangements
with the Bank of America (Bank). Under this arrangement, the Company has a
revolving line of credit of $4.25 million in maximum availability and a term
loan with an original balance of $1.2 million. The May 2006 amendment extended
the expiration of the revolving line of credit to May 31, 2007. Under the
amended financing arrangements, amounts outstanding under the revolving line of
credit and the three year term note bear interest at LIBOR plus 3.25% and 3.45%,
respectively. Availability on a monthly basis under the revolving line is
determined by reference to accounts receivable and inventory on hand which meet
certain Bank criteria (Borrowing Base). The aforementioned term note was paid on
July 31, 2006. At July 31, 2006 and January 31, 2006, the Company had $1,343,000
and $1,243,000, respectively, outstanding under the revolving line of credit and
an effective interest rate of 8.7% and 7.74%, respectively, with $2.9 million of
additional availability under its Borrowing Base.

The amended financing arrangements provides for a new $1.5 million term loan
facility (New Term Loan). The proceeds of the New Term Loan are designated to
refinance the subordinated note with Thomas that at July 31, 2006 and January
31, 2006 had an outstanding balance of $1,492,000 and $3,292,000, respectively.
Advances under the New Term Loan are subject to the Company being in compliance
with its debt covenants with the Bank. The New Term Loan will be repaid in
thirty-six equal monthly principal payments and bears interest at LIBOR plus
3.25%. On August 31, 2006, the Company borrowed $1.5 million under the New Term
Loan and paid the remaining principal and interest due on the subordinated note
with Thomas. As a result of this draw, the Company's Borrowing Base will be
reduced by $750,000 for maximum availability under the revolving line of credit.

The financing arrangements provide for the measurement at the Company's fiscal
year end and at each of the Company's fiscal quarter ends of certain financial
covenants including requiring that the ratio of debt to pro forma earnings
before interest, taxes, depreciation and amortization (EBITDA) not exceed 2.5 to
1 and requiring a pro forma fixed charge coverage ratio of not less than 1.25 to
1. The amended financings also require that the Company meet minimum EBITDA
covenants equal to or exceeding (on a trailing twelve months) $1.2 million for
July 31, 2006, $1.3 million for October 31, 2006 and $1.8 million for January
31, 2007 and for each successive quarter end thereafter. The Bank's consent
continues to be required for acquisitions and divestitures. The Company
continues to pledge the majority of the Company's assets to secure the financing
arrangements.


                                       13

<PAGE>

The amended financing arrangement contains a subjective acceleration clause
which allows the Bank to declare amounts outstanding under the financing
arrangements due and payable if certain material adverse changes occur. We
believe that we will continue to comply with our financial covenants under our
financing arrangement. If our performance does not result in compliance with any
of our financial covenants, or if the Bank seeks to exercise its rights under
the subjective acceleration clause referred to above, we would seek to modify
our financing arrangement, but there can be no assurance that the Bank would not
exercise their rights and remedies under our financing arrangement including
accelerating payment of all outstanding senior and subordinated debt due and
payable.

At July 31, 2006, the Company was in compliance with the covenants of its
amended financing arrangements.

NOTE 7 - PRIVATE OFFERINGS OF COMMON STOCK

On May 4, 2006, the Company completed a private offering of 760,000 shares of
common stock at a price of $2.50 per share for aggregate proceeds of $1.9
million. These shares were registered with the SEC effective July 10, 2006. The
Company used $1.8 million of the proceeds to pay down an equal notional amount
of the subordinated note due Kevin Thomas. The remainder of the proceeds were
used for general corporate purposes.

One of the investors, MSRI SBIC, L.P., which acquired 240,000 shares in the
offering, is controlled by Daniel Levinson, a director of the Company. In
addition, James Quinn, a director of the Company acquired 40,000 shares for his
own account.

On January 28, 2005, the Company sold and issued to MSR I SBIC, L.P., a Delaware
limited partnership ("Investor"), 129,032 shares of the Company's common stock,
pursuant to a Subscription Agreement between the Company and Investor
("Subscription Agreement"). These shares were issued at a purchase price of
$7.75 per share, yielding aggregate proceeds of $999,998. These shares were
issued pursuant to the exemption provided by Section 4(2) of the Securities Act
of 1933, as amended. The Investor is an entity controlled by Daniel Levinson, a
director of the Company. (See Note 5) Pursuant to the Subscription Agreement,
the Company has agreed to issue additional shares of the Company's common stock
to Investor in accordance with the Subscription Agreement based upon the earlier
of (i) the Company's issuance of additional shares of common stock having an
aggregate purchase price of at least $2,500,000 at a price per share less than
$7.75, or (ii) July 31, 2005. The additional shares of common stock to be issued
would equal the price paid by Investor divided by the lower of (i) the weighted
average of all stock sold by the Company prior to July 31, 2005 or; (ii) ninety
percent of the average bid price of the Company's common stock for the thirty
days ended July 31, 2005 if the price was less than $7.75, less the 129,032
shares previously issued. The Company settled the liability for issuance of
additional shares in a non-cash transaction at July 31, 2005 with the issuance
of 95,321 shares of the Company's common stock.

The provision in the Subscription Agreement which allows the Investor to receive
additional shares under certain conditions represents a derivative under
Statement of Financial Accounting Standards No. 133 "Accounting for Derivative
Instruments and Hedging Activities." Accordingly, at January 31, 2005, $139,000
of the proceeds was accounted for as a liability for a derivative financial
instrument. This liability related to the obligation to issue Investor
additional shares under certain conditions. The derivative financial instrument
was subject to adjustment for changes in fair value subsequent to issuance.
During the three and six months ended July 31, 2005, the Company recorded a fair
loss value loss adjustment of $344,000 and $343,000, respectively, which is
recorded in other expense (income), net.


                                       14

<PAGE>

NOTE 8 - INCOME TAXES

The Company had an effective income tax benefit rate of 13% and 29% for the six
and three months ended July 31, 2006 and an effective income tax benefit rate of
12% and 11% for the six and three months ended July 31, 2005. During the six and
three months ended July 31, 2006, the Company's effective income tax benefit
rate decreased by the impact of the amortization of issuance cost for
subordinated debt which is treated as a permanent difference for income tax
reporting purposes. This permanent difference reduced the effective income tax
benefit rate from 38%. During the six and three months ended July 31, 2005, the
Company recorded the change in fair value of the liability for derivative
financial instruments as other expense which is treated as a permanent
difference for income tax reporting purposes. This permanent difference reduced
the income tax benefit rate from 38%.

NOTE 9 - SEGMENT REPORTING

The Company has two reportable operating segments. Operating segments are
defined as components of an enterprise about which separate financial
information is available that is evaluated regularly by the chief operating
decision maker, or decision making group, in deciding how to allocate resources
and assessing performance.

The Company's two operating segments are nutraceutical products and telecom
infrastructure services. The Company conducts its operations through its wholly
owned subsidiaries - VLI and SMC. The "Other" column includes the Company's
corporate and unallocated expenses.

The Company's operating segments are organized in separate business units with
different management, customers, technology and services. The respective
segments account for the respective businesses using the accounting policies in
Note 2 to the Company's Form 10-KSB and Note 2 in this filing. Summarized
financial information concerning the Company's operating segments is shown in
the following tables:

<TABLE>
<CAPTION>
                                                  For the Six Months Ended July 31, 2006
                                       -----------------------------------------------------------
                                                           Telecom
                                       Nutraceutical   Infrastructure
                                          Products        Services         Other      Consolidated
                                       -------------   --------------   -----------   ------------
<S>                                     <C>              <C>            <C>           <C>
Net sales                               $11,040,000      $6,482,000     $        --   $17,522,000
Cost of sales                             8,326,000       5,001,000              --    13,327,000
                                        -----------      ----------     -----------   -----------
  Gross profit                            2,714,000       1,481,000              --     4,195,000
Selling, general and administrative
  expenses                                2,157,000         838,000         925,000     3,920,000
                                        -----------      ----------     -----------   -----------
Income (loss) from operations               557,000         643,000        (925,000)      275,000
Interest expense and amortization of
  subordinated debt issuance costs          208,000          29,000         240,000       477,000
Other income, net                                --           3,000              --         3,000
                                        -----------      ----------     -----------   -----------
Income (loss) before income taxes       $   349,000      $  617,000     $(1,165,000)     (199,000)
                                        ===========      ==========     ===========   -----------
Income tax benefit                                                                         26,000
                                                                                      -----------
Net loss                                                                              $  (173,000)
                                                                                      ===========
Depreciation and amortization           $   273,000      $  231,000     $   271,000   $   775,000
                                        ===========      ==========     ===========   ===========
Amortization of intangibles             $   609,000      $   51,000     $        --   $   660,000
                                        ===========      ==========     ===========   ===========
Goodwill                                $ 6,565,000      $  940,000     $        --   $ 7,505,000
                                        ===========      ==========     ===========   ===========
Total assets                            $17,315,000      $5,427,000     $   418,000   $23,160,000
                                        ===========      ==========     ===========   ===========
Fixed asset additions                   $   189,000      $  415,000     $     8,000   $   612,000
                                        ===========      ==========     ===========   ===========
</TABLE>


                                       15

<PAGE>

<TABLE>
<CAPTION>
                                                 For the Three Months Ended July 31, 2006
                                       -----------------------------------------------------------
                                                           Telecom
                                       Nutraceutical   Infrastructure
                                          Products        Services         Other      Consolidated
                                       -------------   --------------   -----------   ------------
<S>                                     <C>              <C>             <C>          <C>
Net sales                               $ 5,211,000      $3,349,000      $      --    $ 8,560,000
Cost of sales                             3,940,000       2,678,000             --      6,618,000
                                        -----------      ----------      ---------    -----------
    Gross profit                          1,271,000         671,000             --      1,942,000
Selling, general and administrative
  expenses                                1,070,000         424,000        450,000      1,944,000
                                        -----------      ----------      ---------    -----------
Income (loss) from operations               201,000         247,000       (450,000)        (2,000)
Interest expense and amortization of
  subordinated debt issuance costs           81,000          10,000        125,000        216,000
Other income, net                                --           1,000             --          1,000
                                        -----------      ----------      ---------    -----------
Income (loss) before income taxes       $   120,000      $  238,000      $(575,000)      (217,000)
                                        ===========      ==========      =========    -----------
Income tax benefit                                                                         62,000
                                                                                      -----------
Net loss                                                                              $  (155,000)
                                                                                      ===========
Depreciation and amortization           $   139,000      $  119,000      $ 141,000    $   399,000
                                        ===========      ==========      =========    ===========
Amortization of intangibles             $   304,000      $   25,000      $      --    $   329,000
                                        ===========      ==========      =========    ===========
Goodwill                                $ 6,565,000      $  940,000      $      --    $ 7,505,000
                                        ===========      ==========      =========    ===========
Total assets                            $17,315,000      $5,427,000      $ 418,000    $23,160,000
                                        ===========      ==========      =========    ===========
Fixed asset additions                   $    93,000      $  238,000      $   8,000    $   339,000
                                        ===========      ==========      =========    ===========
</TABLE>

<TABLE>
<CAPTION>
                                                  For the Six Months Ended July 31, 2005
                                       -----------------------------------------------------------
                                                           Telecom
                                       Nutraceutical   Infrastructure
                                          Products        Services         Other      Consolidated
                                       -------------   --------------   -----------   ------------
<S>                                    <C>               <C>            <C>           <C>
Net sales                              $  9,252,000      $4,756,000     $        --   $14,008,000
Cost of sales                             6,989,000       3,839,000              --    10,828,000
                                       ------------      ----------     -----------   -----------
    Gross profit                          2,263,000         917,000                     3,180,000
Selling, general and administrative
  expenses                                2,254,000         723,000         849,000     3,826,000
                                       ------------      ----------     -----------   -----------
(Loss) income from operations                 9,000         194,000        (849,000)     (646,000)
Interest expense and amortization of
  subordinated debt issuance costs          132,000          24,000           3,000       159,000
Other expense, net                               --              --       1,925,000     1,925,000
                                       ------------      ----------     -----------   -----------
(Loss) income before income taxes      $   (123,000)     $  170,000     $(2,777,000)   (2,730,000)
                                       ============      ==========     ===========   -----------
Income tax benefit                                                                        322,000
                                                                                      -----------
Net loss                                                                              $(2,408,000)
                                                                                      ===========
Depreciation and amortization          $    166,000      $  198,000     $    58,000   $   422,000
                                       ============      ==========     ===========   ===========
Amortization of intangibles            $    796,000      $   52,000     $        --   $   848,000
                                       ============      ==========     ===========   ===========
Goodwill                               $ 12,375,000      $  940,000     $        --   $13,315,000
                                       ============      ==========     ===========   ===========
Total Assets                           $ 24,310,000      $5,306,000     $   875,000   $30,491,000
                                       ============      ==========     ===========   ===========
</TABLE>


                                       16

<PAGE>

<TABLE>
<CAPTION>
                                                 For the Three Months Ended July 31, 2005
                                       -----------------------------------------------------------
                                                           Telecom
                                       Nutraceutical   Infrastructure
                                         Products         Services         Other      Consolidated
                                       -------------   --------------   -----------   ------------
<S>                                     <C>              <C>            <C>           <C>
Net sales                               $ 4,524,000      $2,328,000     $        --   $ 6,852,000
Cost of sales                             3,559,000       1,932,000              --     5,491,000
                                        -----------      ----------     -----------   -----------
    Gross profit                            965,000         396,000              --     1,361,000
Selling, general and administrative
  expenses                                1,168,000         369,000         449,000     1,986,000
                                        -----------      ----------     -----------   -----------
(Loss) income from operations              (203,000)         27,000        (449,000)     (625,000)
Interest expense and amortization of
  subordinated debt issuance costs           74,000          13,000          16,000       103,000
Other expense, net                               --              --       1,952,000     1,952,000
                                        -----------      ----------     -----------   -----------
(Loss) income before income taxes       $  (277,000)     $   14,000     $(2,417,000)   (2,680,000)
                                        ===========      ==========     ===========   -----------
Income tax benefit                                                                        294,000
                                                                                      -----------
Net loss                                                                              $(2,386,000)
                                                                                      ===========
Depreciation and amortization           $    89,000      $  100,000     $    38,000   $   227,000
                                        ===========      ==========     ===========   ===========
Amortization of intangibles             $   397,000      $   27,000     $        --   $   424,000
                                        ===========      ==========     ===========   ===========
Goodwill                                $12,375,000      $  940,000     $        --   $13,315,000
                                        ===========      ==========     ===========   ===========
Total Assets                            $24,310,000      $5,306,000     $   875,000   $30,491,000
                                        ===========      ==========     ===========   ===========
</TABLE>

NOTE 10 - CONTINGENCIES

On September 17, 2004, Western Filter Corporation (WFC) notified the Company
that WFC believes that the Company breached certain representations and
warranties under the stock purchase agreement dated October 31, 2003 by and
between AI and WFC ("Stock Purchase Agreement"). WFC asserts damages in excess
of the $300,000 escrow which is being held by a third party in connection with
the Stock Purchase Agreement.

On March 22, 2005, WFC filed a complaint in Los Angeles Superior Court alleging
the Company and its executive officers, individually, committed breach of
contract, intentional misrepresentation, concealment and non-disclosure,
negligent misrepresentation and false promise. WFC seeks declaratory relief and
compensatory and punitive damages in an amount to be proven at trial as well as
the recovery of attorney's fees.

Although the Company has reviewed WFC's claim and believes that substantially
all of the claims are without merit, at July 31, 2006, the Company has recorded
an accrual related to this matter of $360,000 for estimated payments and legal
fees related to the claims of WFC that it considers to be probable and that can
be reasonably estimated. It is possible however, that the ultimate resolution of
WFC's claim could result in a material adverse effect on the Company's results
of operations for a particular reporting period. The Company will vigorously
contest WFC's claim.

In the normal course of business, the Company has pending claims and legal
proceedings. It is the opinion of the Company's management, based on information
available at this time, that none of the other current claims and proceedings
will have a material effect on the Company's consolidated financial statements.


                                       17

<PAGE>

NOTE 11 - LETTER OF INTENT

During July 2006, the Company entered into a letter of intent detailing its
proposed merger with Supplement and Nutrition Technologies, Inc. (SNT). The
consummation of this proposed acquisition is contingent upon the completion of
the Company's due diligence, the signing of a definitive purchase and sale
agreement, approval of both companies' board of directors and other conditions.

NOTE 12 - SUBSEQUENT EVENT

During August 2006, the Company entered into a letter of intent detailing its
proposed merger with Gemma Power Systems, LLC (Gemma). The consummation of this
proposed acquisition is contingent upon the completion of the Company's due
diligence, the signing of a definitive purchase and sale agreement, approval of
both companies' board of directors and other conditions.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

This Form 10-QSB contains certain forward-looking statements within the meaning
of Section 21E of the Securities Exchange Act of 1934, as amended, which are
intended to be covered by the safe harbor created thereby. These statements
relate to future events or our future financial performance, including
statements relating to our products, customers, suppliers, business prospects,
financings, investments and effects of acquisitions. In some cases, forward
looking statements can be identified by terminology such as "may," "will,"
"should," "expect," "anticipate," "intend," "plan," "believe," "estimate,"
"potential," or "continue," the negative of these terms or other comparable
terminology. These statements involve a number of risks and uncertainties,
including preliminary information; the effects of future acquisitions and/or
investments; competitive factors; business and economic conditions generally;
changes in government regulations and policies, our dependence upon third-party
suppliers; continued acceptance of our products in the marketplace;
technological changes; and other risks and uncertainties that could cause actual
events or results to differ materially from any forward-looking statement.

GENERAL

Argan, Inc. (the "Company," "we," "us," or "our") conduct our operations through
our wholly owned subsidiaries, Vitarich Laboratories, Inc. ("VLI") that we
acquired in August 2004 and Southern Maryland Cable, Inc. ("SMC") that we
acquired in July 2003. Through VLI, we develop, manufacture and distribute
premium nutritional products. Through SMC, we provide telecommunications
infrastructure services including project management, construction and
maintenance to the Federal Government, telecommunications and broadband service
providers as well as electric utilities.

Private Offering of Common Stock

On May 4, 2006, the Company completed a private offering of 760,000 shares of
common stock at a price of $2.50 per share for aggregate proceeds of $1.9
million. These shares were registered with the SEC effective July 10, 2006. The
Company used $1.8 million of the proceeds to pay down an equal notional amount
of the subordinated note due Kevin Thomas. The remainder of the proceeds were
used for general corporate purposes.

One of the investors, MSRI SBIC, L.P., which acquired 240,000 shares in the
offering, is controlled by Daniel Levinson, a director of the Company. In
addition, James Quinn, a director of the Company acquired 40,000 shares for his
own account.


                                       18

<PAGE>

Subordination of Certain Debt

On January 31, 2005, the Company entered into a Debt Subordination Agreement
("Subordination Agreement") with Kevin J. Thomas ("Thomas"), Southern Maryland
Cable, Inc., a wholly owned subsidiary of the Company ("SMC," and together with
the Company, the "Debtor") and Bank of America, N.A. ("Lender") to reconstitute
as subordinated debt certain additional cash consideration ("Additional Cash
Consideration") that Debtor will owe to Thomas in connection with the Agreement
and Plan of Merger dated August 31, 2004 as amended, by and among the Company,
AGAX/VLI Acquisition Corporation, a subsidiary of the Company, VLI and Thomas
("Merger Agreement").

Pursuant to the Subordination Agreement, Debtor and Thomas have agreed to
reconstitute the Additional Cash Consideration as subordinated debt and in
furtherance thereof, the Company has agreed to execute and deliver to Thomas a
Subordinated Promissory Note in an amount equal to the amount that would
otherwise be due Thomas as Additional Cash Consideration under the Merger
Agreement. Accordingly, under the Subordination Agreement, Debtor subordinated
all of the Junior Debt (as such term is defined in the Subordination Agreement)
to the full extent provided in the Subordination Agreement, and Thomas
transferred and assigned to Lender all of his rights, title and interest in the
Junior Debt and appointed Lender as his attorney-in-fact for the purposes
provided in the Subordination Agreement for as long as any of the Superior Debt
(as such term is defined in the Subordination Agreement) remains outstanding.
Except as otherwise provided in the Subordination Agreement and until such time
that the Superior Debt is satisfied in full, Debtor shall not, among other
things, directly or indirectly, in any way, satisfy any part of the Junior Debt,
nor shall Thomas, among other things, enforce any part of the Junior Debt or
accept payment from Debtor or any other person for the Junior Debt or give any
subordination in respect of the Junior Debt.

The subordinated debt due the former owner of VLI was originally due on August
1, 2006. On May 5, 2006, the Company entered into an agreement with the former
owner of VLI to delay the timing of the payment on the subordinated debt to
August 1, 2007. The Company also has the option to draw on the New Term Loan (as
defined below) to pay the former owner of VLI if we are in compliance with our
debt covenants with the Bank of America, N.A. The remaining principal and
interest due on this note was paid on August 31, 2006, with a draw from the New
Term Loan (as defined below).

Amendment of Financing Arrangements

In May 2006, the Company agreed to amend the existing financing arrangements
with the Bank of America, N.A. (Bank). Under this arrangement, the Company has a
revolving line of credit of $4.25 million in maximum availability and a term
loan with an original balance of $1.2 million. The May 2006 amendment extended
the expiration of the revolving line of credit to May 31, 2007. Under the
amended financing arrangements, amounts outstanding under the revolving line of
credit and the three-year note bear interest at LIBOR plus 3.25% and 3.45%
respectively. Availability on a monthly basis under the revolving line is
determined by reference to accounts receivable and inventory on hand which meet
certain Bank criteria (Borrowing Base). The aforementioned three-year note was
paid in full on July 31, 2006. At July 31, 2006 and January 31, 2006, the
Company also had $1,343,000 and $1,243,000, respectively, outstanding under the
revolving line of credit and an effective interest rate of 8.7% and 7.74%,
respectively, with $2.9 million of additional availability under its Borrowing
Base.

The amended financing arrangements provides for a new $1.5 million term loan
facility (New Term Loan). The proceeds of the New Term Loan are designated to
refinance the subordinated note with Kevin Thomas that at July 31, 2006 and
January 31, 2006, had a current outstanding balance of $1,492,000 and
$3,292,000, respectively, which is due on August 1, 2007. Advances under the New
Term Loan are subject to the Company being in compliance with its debt covenants
with the Bank. The New Term Loan will be repaid in thirty-six equal monthly
principal payments and bears interest at LIBOR plus 3.25%. On August 31, 2006,
the Company borrowed $1.5 million under the New Term Loan and paid the remaining
principal and interest due on the subordinated note with Thomas. As a result of
this draw, the Company's Borrowing Base will be reduced by $750,000 for maximum
availability under the revolving line of credit.


                                       19

<PAGE>

The amended financing arrangements provides for the measurement of certain
financial covenants including requiring the ratio of debt to pro forma earnings
before interest, taxes, depreciation and amortization (EBITDA) not to exceed 2.5
to 1 and requiring pro forma fixed charge coverage ratio not less than 1.25 to
1. The amended financings also require that the Company meet minimum EBITDA
covenants equal to or exceeding (on a trailing twelve months) $1.2 million for
July 31, 2006, $1.3 million for October 31, 2006 and $1.8 million for January
31, 2007 and for each successive quarter end thereafter. The Bank's consent
continues to be required for acquisitions and divestitures. The Company
continues to pledge the majority of the Company's assets to secure the financing
arrangements.

The amended financing arrangement contains a subjective acceleration clause
which allows the Bank to declare amounts outstanding under the financing
arrangement due and payable if certain material adverse changes occur. We
believe that we will continue to comply with our financial covenants under our
financing arrangement. If our performance does not result in compliance with any
of our financial covenants, or if the Bank seeks to exercise its rights under
the subjective acceleration clause referred to above, we would seek to modify
our financing arrangement, but there can be no assurance that the Bank would not
exercise their rights and remedies under our financing arrangement including
accelerating payment of all outstanding senior and subordinated debt due and
payable.

Holding Company Structure

We intend to make additional acquisitions and/or investments. We intend to have
more than one industrial focus and to identify those companies that are in
industries with significant potential to grow profitably both internally and
through acquisitions. We expect that companies acquired in each of these
industrial groups will be held in separate subsidiaries that will be operated in
a manner that best provides cashflow and value for the Company.

We are a holding company with no operations other than our investments in VLI
and SMC. At July 31, 2006, there were no restrictions with respect to dividends
or other payments from VLI and SMC to the Company.

Nutritional Products

We are dedicated to the research, development, manufacture and distribution of
premium nutritional supplements, whole-food dietary supplements and personal
care products. Several of these products have garnered honors including the
National Nutritional Foods Association's prestigious Peoples Choice Awards for
best products of the year in its respective category.

We provide nutrient-dense, super-food concentrates, vitamins and supplements.
Our customers include health food store chains, mass merchandisers, network
marketing companies, pharmacies and major retailers.

We intend to enhance our position in the fast growing global nutrition industry
through our innovative product development and research. We believe that we will
be able to expand our distribution channels by providing continuous quality
assurance and by focusing on timely delivery of superior nutraceutical products.

We are focused on efficiently utilizing the strong cash flow potential from
manufacturing nutritional products. To ensure that working capital is
effectively allocated, we closely monitor our inventory turns as well as the
number of days sales that we have in our accounts receivable.


                                       20

<PAGE>

Telecom Infrastructure Services

We currently provide inside plant, premise wiring services to the Federal
Government and have plans to expand that work to commercial customers who
regularly need upgrades in their premise wiring systems to accommodate
improvements in security, telecommunications and network capabilities.

We continue to participate in the expansion of the telecommunications industry
by working with various telecommunications providers. We are actively pursuing
contracts with a wide variety of telecommunications providers. We provide
maintenance and upgrade services for their outside plant systems that increase
the capacity of existing infrastructure. We also provide outside plant services
to the power industry by providing maintenance and upgrade services to
utilities.

We intend to emphasize our high quality reputation, outstanding customer base
and highly motivated work force in competing for larger and more diverse
contracts. We believe that our high quality and well maintained fleet of
vehicles and construction machinery and equipment is essential to meet
customers' needs for high quality and on-time service. We are committed to
invest in our repair and maintenance capabilities to maintain the quality and
life of our equipment. Additionally, we invest annually in new vehicles and
equipment.

Letters of Intent

During July 2006, the Company entered into a letter of intent detailing its
proposed merger with Supplement and Nutrition Technologies, Inc. (SNT). The
consummation of this proposed acquisition is contingent upon the completion of
the Company's due diligence, the signing of a definitive purchase and sale
agreement, approval of both companies' board of directors and other conditions.

During August 2006, the Company entered into a letter of intent detailing its
proposed merger with Gemma Power Systems, LLC (Gemma). The consummation of this
proposed acquisition is contingent upon the completion of the Company's due
diligence, the signing of a definitive purchase and sale agreement, approval of
both companies' board of directors and other conditions.

CRITICAL ACCOUNTING POLICIES

Management is required to make judgments, assumptions and estimates that affect
the amounts reported when we prepare financial statements and related
disclosures in conformity with generally accepted accounting principles. Note 2
contained in the Company's consolidated financial statements for the year ended
January 31, 2006 included in the Company's Annual Report contained in Form
10-KSB, as filed with the Securities and Exchange Commission describes the
significant accounting policies and methods used in the preparation of our
consolidated financial statements. Estimates are used for, but not limited to
our accounting for revenue recognition, allowance for doubtful accounts,
inventory valuation, long-lived assets and deferred income taxes. Actual results
could differ from these estimates. The following critical accounting policies
are impacted significantly by judgments, assumptions and estimates used in the
preparation of our consolidated financial statements. If future conditions and
results are different than our assumptions and estimates, materially different
amounts could be reported.

Revenue Recognition


                                       21

<PAGE>

Vitarich Laboratories, Inc.

We manufacture products for our customers based on their orders. We typically
ship the orders immediately after production keeping relatively little on-hand
as finished goods inventory. We recognize customer sales at the time title and
the risks and rewards of ownership passes to our customer which is generally
when orders are shipped. Sales are recognized on a net basis which reflect
reductions for certain product returns and discounts. Cost of goods sold and
finished goods inventory sold include materials and direct labor as well as
other direct costs combine with allocations of indirect operational costs.

Southern Maryland Cable, Inc.

We generate revenue under various arrangements, including contracts under which
revenue is based on a fixed price basis and on a time and materials basis.
Revenues from time and materials contracts are recognized when the related
service is provided to the customer. Revenues from fixed price contracts,
including a portion of estimated profit, are recognized as services are
provided, based on costs incurred and estimated total contract costs using the
percentage of completion method.

The timing of billing to customers varies based on individual contracts and
often differs from the period of revenue recognition. Estimated earnings in
excess of billings and billings in excess of estimated earnings totaled $581,000
and $7,000, respectively, at July 31, 2006.

Contract costs are recorded when incurred and include direct labor and other
direct costs combined with allocations of operational indirect costs. Management
periodically reviews the costs incurred and revenue recognized from contracts
and adjusts recognized revenue to reflect current expectations. Provisions for
estimated losses on incomplete contracts are provided in full in the period in
which such losses become known.

Inventories

Inventories are stated at the lower of cost or market (net realizable value).
Cost is determined on the first-in first-out (FIFO) method. Appropriate
consideration is given to obsolescence, excessive inventory levels, product
deterioration and other factors in evaluating net realizable value.

Impairment of Long-Lived Assets, Including Definite Lived Intangible Assets

Long-lived assets, consisting primarily of property and equipment, are reviewed
for impairment whenever events or changes in circumstances indicate that the
carrying amount should be assessed pursuant to SFAS No. 144, "Accounting for the
Impairment or Disposal of Long-Lived Assets." We determine whether any
impairment exists by comparing the carrying value of these long-lived assets to
the undiscounted future cash flows expected to result from the use of these
assets. In the event we determine that an impairment exists, a loss would be
recognized based on the amount by which the carrying value exceeds the fair
value of the assets, which is generally determined by using quoted market prices
or valuation techniques such as the discounted present value of expected future
cash flows, appraisals, or other pricing models as appropriate.

Goodwill and Other Indefinite Lived Intangible Assets

In connection with the acquisitions of VLI and SMC, the Company has substantial
goodwill and intangible assets including contractual customer relationships,
proprietary formulas, non-compete agreements and trade names. In accordance with
SFAS 142 "Goodwill and Other Intangible Assets," the Company reviews for
impairment, at least annually, goodwill and intangible assets deemed to have an
indefinite life.


                                       22

<PAGE>

Goodwill impairment is determined using a two-step process. The first step of
the goodwill impairment test is to identify a potential impairment by comparing
the fair value of a reporting unit with its carrying amount, including goodwill.
The estimates of fair value of a reporting unit, generally a Company's operating
segment, is determined using various valuation techniques, with the principal
techniques being a discounted cash flow analysis and market multiple valuation.
A discounted cash flow analysis requires making various judgmental assumptions,
including assumptions about future cash flows, growth rates and discount rates.
Developing assumptions for the Company's entrepreneurial business requires
significant judgment and to a great extent relies on the Company's ability to
successfully determine trends with respect to customers, industry and regulatory
environment. The assumptions, including assumptions about future flows and
growth rates, are based on the Company's budget and business plans as well as
industry trends with respect to customers and other manufacturers' and
distributors' sales and margins. The Company reviews trends for publicly traded
companies which either compete with the Company to provide services or the types
of products the Company produces or are users of the types of services and
products provided by the Company. Changes in economic and operating conditions
impacting these assumptions could result in goodwill impairment in future
periods. Discount rate assumptions are based on the Company's subjective
assessment of the risk inherent in the respective reporting units. Risks which
the Company faces in its business include the public's perception of our
integrity and the safety and quality of our products and services. In addition,
in the industries that we operate we are subject to rapidly changing consumer
demands and preferences. The Company also operates in competitive industries. We
are not assured that customers or potential customers will regard our products
and services as sufficiently distinguishable from our competitors' product and
service offerings. If after taking into consideration industry and Company
trends, the fair value of a reporting unit exceeds its carrying amount, goodwill
of the reporting unit is not deemed impaired and the second step of the
impairment test is not performed. If the carrying amount of a reporting unit
exceeds its fair value, the second step of the goodwill impairment test compares
the implied fair value of the reporting unit's goodwill with the carrying amount
of that goodwill. If the carrying amount of the reporting unit's goodwill
exceeds the implied fair value of that goodwill, an impairment loss is
recognized in an amount equal to that excess. The implied fair value of goodwill
is determined in the same manner as the amount of goodwill recognized in a
business combination. Accordingly, the fair value of the reporting unit is
allocated to all of the assets and liabilities of that unit (including any
unrecognized intangible assets) as if the reporting unit had been acquired in a
business combination and the fair value of the reporting unit was the purchase
price paid to acquire the reporting unit.

The Company will test for impairment of Goodwill and other intangible assets
more frequently if events or changes in circumstances indicate that the asset
might be impaired.

Contractual Customer Relationships

Southern Maryland Cable, Inc. - The fair value of the Contractual Customer
Relationships (CCR's) was determined at the time of the acquisition of SMC by
discounting the cash flows expected from SMC's continued relationships with
three customers - General Dynamics Corp. (GD), Verizon Communications (VZ) and
Southern Maryland Electric Cooperative (SMECO). Expected cash flows were based
on historical levels, current and anticipated projects and general economic
conditions. In some cases, the estimates of future cash flows reflect periods
beyond those of the current contracts in place. While SMC's relationship with GD
is relatively recent, SMC has performed work for VZ and SMECO for approximately
twenty years and ten years, respectively. The long-term relationship with VZ and
SMECO affected the discount rate used to discount cost of capital and SMC's
asset mix. We are amortizing the CCR's over a seven year weighted average life
given the long standing relationships SMC has with Verizon and SMECO.


                                       23

<PAGE>

Vitarich Laboratories, Inc. - The fair value of the Contractual Customer
Relationships at VLI (VCCR's) was determined at the time of the acquisition of
VLI by identifying long established customer relationships in which VLI has a
pattern of recurring purchase and sales orders. The Company estimated expected
cash flows attributable to these existing customer relationships factoring in
market place assumptions regarding future contract renewals, customer attrition
rates and forecasted expenses to maintain the installed customer base. These
cash flows were then discounted based on a rate that reflects the perceived risk
of the VCCR's, the Company's estimated weighted average cost of capital and
VLI's asset mix. VLI has had a relationship of five years or more with most if
its currently significant customers. We are amortizing VCCR's over a five year
life based on our expectations of continued cash flows from these relationships
and our history of maintaining relationships.

Trade Name

The fair value of the SMC trade name was estimated using a relief-from-royalty
methodology. We determined that the useful life of the trade name was indefinite
since it is expected to contribute directly to future cash flows in perpetuity.
The Company has also considered the effects of demand and competition including
its customer base. While SMC is not a nationally recognized trade name, it is a
regionally recognized name in the Mid-Atlantic region, SMC's primary region of
operations.

We are using the relief-from-royalty method described above to test the trade
name for impairment annually on November 1 and on an interim basis if events or
changes in circumstances between annual tests indicate the trade name might be
impaired.

Proprietary Formulas

The Fair Value of the Proprietary Formulas (PFs) was determined at the time of
the acquisition of VLI by discounting the cash flows expected from developed
formulations based on relative technology contribution and estimates regarding
product lifecycle and development costs and time. The expected cash flows were
discounted based on a rate that reflects the perceived risk of the PFs, the
estimated weighted average cost of capital and VLI's asset mix. We are
amortizing the PFs over a three year life based on the estimated contributory
life of the proprietary formulations utilizing estimated historical product
lifecycles and changes in technology.

Non-Compete Agreement

The fair value of the Non-Compete Agreement (NCA) was determined at the time of
acquisition of VLI by discounting the estimated reduction in the cash flows
expected if one key employee, the former sole shareholder of VLI, were to leave.
The key employee signed a non-compete clause prohibiting the employee from
competing directly or indirectly for five years. The estimated reduced cash
flows were discounted based on a rate that reflects the perceived risk of the
NCA, the estimated weighted average cost of capital and VLI's asset mix. We are
amortizing the NCA over five years, the length of the non-compete agreement.

Derivative Financial Instruments

The Company accounts for derivative financial instruments in accordance with
Statement of Financial Accounting Standards ("SFAS") No. 133 "Accounting for
Derivative Instruments and Hedging Activities" and Emerging Issues Task Force
Issue No. 00-19, "Accounting for Derivative Financial Instruments Indexed to,
and Potentially Settled in a Company's Own Stock." The derivative financial
instruments are carried at fair value with changes in fair value recorded as
other expense, net. The determination of fair value for our derivative financial
instruments is subject to the volatility of our stock price as well as certain
underlying assumptions which include the probability of raising additional
capital.


                                       24

<PAGE>

Deferred Tax Assets and Liabilities

We account for income taxes under the asset and liability method. The approach
requires the recognition of deferred tax assets and liabilities for the expected
future tax consequences of temporary differences between the carrying amounts
and the tax basis of assets and liabilities. Developing our provision for income
taxes requires significant judgment and expertise in Federal and state income
tax laws, regulations and strategies, including the determination of deferred
tax assets and liabilities and, if necessary, any valuation allowances that may
be required for deferred tax assets.

WESTERN FILTER CORPORATION LITIGATION

On September 17, 2004, Western Filter Corporation ("WFC") notified the Company
that WFC believes that the Company breached certain representations and
warranties under the stock purchase agreement dated October 31, 2003 by and
between Argan, Inc. and WFC ("Stock Purchase Agreement"). WFC asserts damages in
excess of the $300,000 escrow which is being held by a third party in connection
with the Stock Purchase Agreement.

On March 22, 2005, WFC filed a complaint in Los Angeles Superior Court alleging
the Company and its executive officers, individually, committed breach of
contract, intentional misrepresentation, concealment and non-disclosure,
negligent misrepresentation and false promise. WFC seeks declaratory relief and
compensatory and punitive damages in an amount to be proven at trial as well as
the recovery of attorneys' fees.

Although the Company has reviewed WFC's claim and believes that substantially
all of the claims are without merit, at July 31, 2006, the Company had an
accrual related to this matter of $360,000 for estimated payments and legal fees
related to the claims of WFC that it considers to be probable and that can be
reasonably estimated. It is possible, however, that the ultimate resolution of
WFC's claim could result in a material adverse effect on the Company's results
of operations for a particular reporting period. The Company will vigorously
contest WFC's claim.


                                       25

<PAGE>

CONSOLIDATED RESULTS OF OPERATIONS

For the three months ended July 31:

<TABLE>
<CAPTION>
                                                                        Increase    Percent
                                              2006           2005      (Decrease)    Change
                                           ----------   ------------   ----------   -------
<S>                                        <C>          <C>            <C>           <C>
Net sales
    Nutraceutical products                 $5,211,000   $  4,524,000    $ 687,000      15.0%
    Telecom infrastructure services         3,349,000      2,328,000    1,021,000      44.0
                                           ----------   ------------   ----------    ------
Net Sales                                   8,560,000      6,852,000    1,708,000      25.0
Cost of sales
    Nutraceutical products                  3,940,000      3,559,000      381,000      11.0
    Telecom infrastructure services         2,678,000      1,932,000      746,000      39.0
                                           ----------   ------------   ----------    ------
  Gross profit                              1,942,000      1,361,000      581,000      43.0
Selling, general and administrative
  expenses                                  1,944,000      1,986,000      (42,000)     (2.0)
                                           ----------   ------------   ----------    ------
    Income (loss) from operations              (2,000)      (625,000)     623,000    (100.0)
Interest expense and amortization of
  subordinated debt issuance costs            216,000        103,000      113,000     110.0
Other (income ) expense, net                   (1,000)     1,952,000   (1,953,000)   (100.0)
                                           ----------   ------------   ----------    ------
    Income (loss) from operations before
      income taxes                           (217,000)    (2,680,000)   2,463,000     (92.0)
Income tax benefit                             62,000        294,000     (232,000)    (79.0)
                                           ----------   ------------   ----------    ------
Net loss                                   $ (155,000)   $(2,386,000)  $2,231,000     (94.0)
                                           ==========   ============   ==========    ======
</TABLE>

Net sales

Net sales of nutraceutical products increased by $687,000 or 15% for the three
months ended July 31, 2006 compared to the three months ended July 31, 2005,
primarily due to increased sales to one of our largest customers, Rob Reiss
Companies (RRC) as well as to six new customers.

Net sales of telecommunications infrastructure services increased by $1,021,000
or 44% for the three months ended July 31, 2006 compared to the three months
ended July 31, 2005, primarily due to increased sales to VZ, SMECO and
Electronic Data Systems Corp. (EDS) which offset the decline in business with GD
whose contract with SMC was completed last year.

Cost of sales

For the three months ended July 31, 2006, cost of sales for nutraceutical
products was 76% of net sales for nutraceutical products. For the three months
ended July 31, 2005, cost of sales was 79% of net sales for nutraceutical
products. VLI experienced a lower percentage of cost of sales during the three
months ended July 31, 2006 due to VLI passing along increased costs of
non-nutritional materials whose cost was affected by the rise in oil prices. In
addition, VLI has been reviewing its vendor relationships to ensure quality
materials are obtained at competitive prices.

For the three months ended July 31, 2006, cost of sales for telecommunications
infrastructure services was 80% of net sales of telecommunications
infrastructure services. For the three months ended July 31, 2005, cost of sales
was 83% of net sales of telecommunications infrastructure services. SMC
experienced improved percentage margin performance due primarily to more
effective utilization of construction personnel and equipment assigned to VZ and
EDS as the net sales to both customers increased.


                                       26

<PAGE>

Selling, general and administrative expenses

Consolidated selling, general and administrative expenses were $1,944,000 or 23%
of consolidated net sales for the three months ended July 31, 2006 compared to
$1,973,000 or 29% of consolidated net sales for the three months ended July 31,
2005. VLI had lower amortization of purchased intangibles of $93,000 due to
lower basis in such assets in current fiscal year.

Interest expense and amortization of subordinated debt issuance costs

Consolidated interest expense and amortization of subordinated debt issuance
costs increased by $113,000 or 110% for the three months ended July 31, 2006
compared to the three months ended July 31, 2005, due primarily to the
amortization of issuance costs for the subordinated debt of $128,000 for the
three months ended July 31, 2006. The subordinated note was issued on June 30,
2005 resulting in one month of amortization for the three months ended July 31,
2005.

Other (income) expense, net

Other (income) expense, net changed from $1,952,000 in expense for the three
months ended July 31, 2005 to income of $1,000 for the three months ended July
31, 2006, primarily due to the fair value loss of the liability for derivative
financial instrument of $1,952,000 realized during the three months ended July
31, 2005.

Income tax benefit

The Company's consolidated effective income tax benefit rate was 29% for the
three months ended July 31, 2006 compared to an 11% effective income tax benefit
rate for the three months ended July 31, 2005.

During the three months ended July 31, 2006, the Company's effective income tax
rate benefit was increased by the impact of the amortization of issuance cost
for subordinated debt which is treated as a permanent difference for income tax
reporting purposes. This permanent difference reduced the effective income tax
benefit rate from 38%.

For the three months ended July 31, 2005, the Company's effective income tax
benefit rate was decreased by the impact of the fair value adjustment for
liability for derivative financial instrument which is a permanent difference
for income tax reporting purposes. This permanent difference reduced the
effective income tax benefit rate from 38%.

For the six months ended July 31:

<TABLE>
<CAPTION>
                                                                     Increase     Percent
                                           2006         2005         (Decrease)    Change
                                       -----------   -----------   ------------   -------
<S>                                    <C>           <C>            <C>           <C>
Net sales
    Nutraceutical products             $11,040,000   $ 9,252,000    $ 1,788,000     19.0%
    Telecom infrastructure services      6,482,000     4,756,000      1,726,000     36.0
                                       -----------   -----------    -----------
Net Sales                               17,522,000    14,008,000      3,514,000     25.0
Cost of sales
    Nutraceutical products               8,326,000     6,989,000      1,337,000     19.0
    Telecom infrastructure services      5,001,000     3,839,000      1,162,000     30.0
                                       -----------   -----------    -----------
  Gross profit                           4,195,000     3,180,000      1,015,000     32.0
Selling, general and administrative
  expenses                               3,920,000     3,826,000         94,000      2.0
                                       -----------   -----------    -----------
    Income (loss) from operations          275,000      (646,000)       921,000   (143.0)
Interest expense and amortization of
    subordinated debt issuance costs       477,000       159,000        318,000    200.0
Other (income) expense, net                 (3,000)    1,925,000     (1,928,000)  (100.0)
                                       -----------   -----------    -----------
    Loss from operations before
      income taxes                        (199,000)   (2,730,000)     2,531,000    (93.0)
Income tax benefit                          26,000       322,000       (296,000)   (92.0)
                                       -----------   -----------    -----------
Net loss                               $  (173,000)  $(2,408,000)   $ 2,235,000    (93.0)
                                       ===========   ===========    ===========
</TABLE>


                                       27

<PAGE>

Net sales

Net sales of nutraceutical products increased by $1,788,000 or 19% for the six
months ended July 31, 2006 compared to the six months ended July 31, 2005,
primarily due to increased sales to one of our largest customers Rob Reiss
Companies (RRC) as well as to six new customers.

Net sales of telecommunications infrastructure services increased by $1,726,000
or 36% for the six months ended July 31, 2006 compared to the six months ended
July 31, 2005, primarily due to increased sales to VZ, SMECO and Electronic Data
Systems Corp. (EDS) which offset the decline in business with GD whose contract
with SMC was completed last year.

Cost of sales

For the six months ended July 31, 2006, cost of sales for nutraceutical products
was 75% of net sales for nutraceutical products. For the six months ended July
31, 2005, cost of sales was 76% net sales for nutraceutical products. VLI
experienced a lower percentage of cost of sales during the six months ended July
31, 2006 due to VLI passing along to customers increased costs of
non-nutritional materials whose cost was affected by the rise in oil prices. In
addition, VLI has been reviewing its vendor relationships to ensure quality and
competitive prices.

For the six months ended July 31, 2006, cost of sales for telecommunications
infrastructure services were 77% of net sales of telecommunications
infrastructure services. For the six months ended July 31, 2005, cost of sales
was 81% of net sales of telecommunications infrastructure services. SMC
experienced improved percentage margin performance due primarily to more
effective utilization of construction personnel and equipment assigned to VZ and
EDS as the net sales to both customers increased.

Selling, general and administrative expenses

Consolidated selling, general and administrative expenses were $3,920,000 or 22%
of consolidated net sales for the six months ended July 31, 2006 compared to
$3,826,000 or 27% of consolidated net sales for the six months ended July 31,
2005. SMC increased its selling, general and administrative expenses due to the
hiring of additional sales support personnel. In addition, SMC has incurred
expense for bonuses as a result of improved financial performance for the six
months ended July 31, 2006. Corporate expenses increased due to higher
professional accounting service fees.

Interest expense and amortization of subordinated debt issuance costs

Consolidated interest expense and amortization of subordinated debt issuance
costs increased by $318,000 or 200% for the six months ended July 31, 2006
compared to the six months ended July 31, 2005, due primarily to increased
interest expense for subordinated debt of $137,000 and amortization of issuance
cost for the subordinated debt of $257,000 for the six months ended July 31,
2006. The subordinated note was issued on June 30, 2005 resulting in one month
of amortization for the six months ended July 31, 2005.

Other (income) expense, net


                                       28

<PAGE>

Other (income) expense, net changed from $1,925,000 in expense for the six
months ended July 31, 2005 to income of $3,000 for the six months ended July 31,
2006, primarily due to the fair value loss of the liability for derivative
financial instrument of $1,929,000 realized during the six months ended July 31,
2005.

Income tax benefit

The Company's consolidated effective income tax benefit rate was 13% for the six
months ended July 31, 2006 compared to a 12% effective income tax benefit rate
for the six months ended July 31, 2005.

During the six months ended July 31, 2006, the Company's effective income tax
benefit rate was increased by the impact of the amortization of issuance cost
for subordinated debt which is treated as a permanent difference for income tax
reporting purposes. This permanent difference reduced the effective income tax
benefit rate from 38%.

For the six months ended July 31, 2005, the Company's effective income tax
benefit rate was increased by the impact of the fair value adjustment for
liability for derivative financial instruments which is a permanent difference
for income tax reporting purposes. This permanent difference reduced the
effective income tax benefit rate from 38%.

LIQUIDITY AND CAPITAL RESOURCES

Cash Position and Indebtedness

We had $2.0 million in working capital at July 31, 2006, including $161,000 of
cash and cash equivalents. In addition we had $2.9 million available under
credit facilities.

Working capital increased by $485,000 to $2.0 million at July 31, 2006 from $1.5
million at January 31, 2006. Components of the Company's cash flow provided by
operations during the six months ended July 31, 2006 contributed to the increase
in working capital. Accounts receivable increased by $537,000 and prepaid
expenses and other current assets increased by $337,000 and due to affiliates
decreased by $108,000, which was offset, in part by a decrease in inventories of
$543,000. The Company had a loss before taxes of $199,000 for the six months
ended July 31, 2006. The Company's non-cash expenses included in the
determination of income before taxes included $660,000 for amortization of
purchase intangibles and $775,000 for depreciation and amortization.

Cash Flows

Net cash provided by operations for the six months ended July 31, 2006 was
$953,000 compared with $754,000 of cash provided by operations for the six
months ended July 31, 2005 due to the improved financial performance of both SMC
and VLI. For the six months ended July 31, 2006, SMC had income from operations
of $643,000 compared to income from operations of $194,000 for the six months
ended July 31, 2005. Net sales from VZ increased by $1.3 million due to SMC
reestablishing a contractual relationship with VZ which had previously been
discontinued. In July 2004, SMC lost a significantly profitable contract with
VZ. In September 2005, SMC commenced work on an underground telecommunications
infrastructure services contract with VZ which had been previously awarded to a
third party which did not perform to VZ's satisfaction. In addition, SMC
experienced strong revenue growth from SMECO and EDS. During the six months
ended July 31, 2006, VLI had income from operations of $557,000 compared to
income from operations of $9,000 for the six months ended July 31, 2005. VLI
experienced strong revenue growth from one of its most significant customers,
RRC as well as from six new customers.


                                       29

<PAGE>

During the six months ended July 31, 2006, accounts receivable used cash of
$537,000. Increases in revenue at both SMC and VLI resulted in the substantial
increase in accounts receivable which was offset by inventories, net which
provided cash flows of $543,000. VLI exercised tighter controls over inventory
levels as it experienced strong revenue growth.

During the six months ended July 31, 2006, net cash used for investing
activities was $608,000 compared to net cash used for investing activities of
$1,063,000 for the six months ended July 31, 2005. SMC paid for new directional
boring equipment and trucks to respond to opportunities for additional customer
work.

For the six months ended July 31, 2006, net cash used by financing activities
was $189,000 compared to cash provided by financing activities of $266,000 for
the six months ended July 31, 2005. The change from net cash provided by
financing activities during the six months ended July 31, 2005 to net cash used
during the six months ended July 31, 2006 is due to payments made on the line of
credit, the term loan, and the subordinated note with Kevin Thomas, offset by
net proceeds from the sale of stock. During the six months ended July 31, 2005,
the Bank of America, N.A. released $304,000 in previously escrowed funds in
accordance with the amended financing arrangements of April 2005 which offset
the net pay down of the Company's line of credit and long term debt.

In May 2006, the Company agreed to amend the existing financing arrangements
with the Bank of America, N.A. (Bank). Under this arrangement, the Company has a
revolving line of credit of $4.25 million in maximum availability and a term
loan with an original balance of $1.2 million. The May 2006 amendment extended
the expiration of the revolving line of debt to May 31, 2007. Under the amended
financing arrangements, amounts outstanding under the revolving line of credit
and the three-year note bear interest at LIBOR plus 3.25% and 3.45%,
respectively. Availability on a monthly basis under the revolving line is
determined by reference to accounts receivable and inventory on hand which meet
certain Bank criteria (Borrowing Base). The aforementioned three-year note was
paid in full on July 31, 2006. At July 31, 2006 and January 31, 2006, the
Company had $1,343,000 and $1,243,000, respectively, outstanding under the
revolving line of credit and an effective interest rate of 8.7% and 7.74%,
respectively, with $2.9 million of additional availability under its Borrowing
Base.

The amended financing arrangement provides for a new $1.5 million term loan
facility (New Term Loan). The proceeds of the New Term Loan are designated to
refinance the subordinated note with Kevin Thomas that had at July 31, 2006 and
January 31, 2006 an outstanding balance of $1,492,000 and $3,292,000,
respectively, which is due on August 1, 2007. Advances under the New Term Loan
are subject to the Company being in compliance with its debt covenants with the
Bank. The New Term Loan will be repaid in thirty-six equal monthly principal
payments and bear interest at LIBOR plus 3.25%. On August 31, 2006, the Company
borrowed $1.5 million under the New Term Loan and paid the remaining principal
and interest due on the subordinated note with Thomas. As a result of this draw,
the Company's Borrowing Base will be reduced by $750,000 for maximum
availability under the revolving line of credit.

The amended financing arrangements provides for the measurement of certain
financial covenants including requiring the ratio of debt to pro forma earnings
before interest, taxes, depreciation and amortization (EBITDA) not to exceed 2.5
to 1 and requiring pro forma fixed charge coverage ratio not less than 1.25 to
1. The amended financing arrangements also provide a requirement that the
Company meet minimum EBITDA covenants equal to or exceeding (on a trailing
twelve months) $1.2 million for July 31, 2006, $1.3 million for October 31, 2006
and $1.8 million for January 31, 2007 and for each successive quarter end
thereafter. Bank consent continues to be required for acquisitions and
divestitures. The Company continues to pledge the majority of the Company's
assets to secure the financing arrangements.


                                       30

<PAGE>

The amended financing arrangement contains a subjective acceleration clause
which allows the Bank to declare amounts outstanding under the financing
arrangement due and payable if certain material adverse changes occur. We
believe that we will continue to comply with our financial covenants under our
financing arrangement. If our performance does not result in compliance with any
of our financial covenants, or if the Bank seeks to exercise its rights under
the subjective acceleration clause referred to above, we would seek to modify
our financing arrangement, but there can be no assurance that the Bank would not
exercise their rights and remedies under our financing arrangement including
accelerating payment of all outstanding senior and subordinated debt due and
payable.

At July 31, 2006, the Company was in compliance with the covenants of its
amended financing arrangements.

Management believes that cash generated from the Company's operations combined
with capital resources available under its renewed line of credit is adequate to
meet the Company's future operating cash needs. Any future acquisitions, other
significant unplanned costs or cash requirements may require the Company to
raise additional funds through the issuance of debt and equity securities. There
can be no assurance that such financing will be available on terms acceptable to
the Company, or at all. If additional funds are raised by issuing equity
securities, significant dilution to the existing stockholders may result.

Customers

During the six months ended July 31, 2006, we provided nutritional and
whole-food supplements as well as personal care products to customers in the
global nutrition industry and services to telecommunications and utilities
customers as well as to the Federal Government, through a contract with
Electronic Data Systems Corp. (EDS). Certain of our more significant customer
relationships are with TriVita, Inc. (TVC), Rob Reiss Companies (RRC), Verizon
Communications, Inc. (VZ), Southern Maryland Electrical Cooperative (SMECO),
EDS, CyberWize.com, Inc. (C), and Orange Peel Enterprises, Inc. (OPE). TVC, RRC,
C and OPE are VLI customers. SMC's significant customers are VZ, SMECO and EDS.
TVC, RRC, C and OPE accounted for approximately 17%, 15%, 7% and 4% of
consolidated net sales during the six months ended July 31, 2006. VZ, SMECO and
EDS accounted for approximately 10%, 11% and 9% of consolidated net sales during
the six months ended July 31, 2006. Combined TVC, RRC, VZ, SMECO, EDS, C and OPE
accounted for approximately 75% of consolidated net sales during the six months
ended July 31, 2006.

Seasonality

The Company's telecom infrastructure services operations are expected to have
seasonally weaker results in the first and fourth quarters of the year, and may
produce stronger results in the second and third quarters. This seasonality is
primarily due to the effect of winter weather on outside plant activities as
well as reduced daylight hours and customer budgetary constraints. Certain
customers tend to complete budgeted capital expenditures before the end of the
year, and postpone additional expenditures until the subsequent fiscal period.

IMPACT OF CHANGES IN ACCOUNTING STANDARDS

In July 2006, the Financial Accounting Standards Board (FASB) issued FASB
Interpretation No. 48, Accounting for Uncertainty in Income Taxes - an
interpretation of FASB Statement No. 109 ("FIN 48"), which clarifies the
accounting for uncertainty in income tax positions. FIN 48 requires that the
Company recognize in the consolidated financial statements the impact of a tax
position that is more likely than not to be sustained upon examination based on
the technical merits of the position. The provisions of FIN 48 will be effective
for the Company, as of the beginning of the Company's fiscal year ending January
31, 2008, with the cumulative effect of the change in accounting principle
recorded as an adjustment to opening retained earnings. The Company is currently
evaluating the impact of adopting FIN 48 on the consolidated financial
statements.


                                       31

<PAGE>

ITEM 3.   CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

As of the end of the period covered by this report, the Company carried out an
evaluation, under the supervision and with the participation of the Company's
management, including its Chief Executive Officer and its Chief Financial
Officer, of the effectiveness of the design and operation of the Company's
disclosure controls and procedures (as defined in Rule 13a-15 of the Securities
Exchange Act of 1934). Based on that evaluation, our Chief Executive Officer and
our Chief Financial Officer have concluded that the Company's current disclosure
controls and procedures are effective in timely alerting them of material
information relating to the Company that is required to be disclosed by the
Company in the reports it files or submits under the Securities Exchange Act of
1934.

Changes in Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal
control over financial reporting, as such term is defined in Rules 13a-15(f)
under the Securities Exchange Act of 1934 and for of the effectiveness of
internal control over financial reporting.

There have been no changes in the Company's internal control over financial
reporting that occurred during the quarter ended July 31, 2006 that have
materially affected, or are reasonably likely to materially affect the Company's
internal control over financial reporting.

                                     PART ll
                                OTHER INFORMATION

ITEM 1.  LEGAL PROCEEDINGS

(See Note 10 of the financial statements)

ITEM 2.  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

On May 4, 2006, the Company completed a private offering of 760,000 shares of
common stock at a price of $2.50 per share for aggregate proceeds of $1.9
million. These shares were registered with the SEC effective July 10, 2006. The
Company used $1.8 million of the proceeds to pay down an equal notional amount
of the subordinated note due Kevin Thomas. The remainder of the proceeds were
used for general corporate purposes.

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES

                None.

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

                None.

ITEM 5.  OTHER INFORMATION

                None.


                                       32

<PAGE>

ITEM 6.  EXHIBITS

       Exhibit No.    Title
       -----------    -----
      Exhibit: 31.1   Certification of Chief Executive Officer, pursuant to Rule
                      13a-14(c) under the Securities Exchange Act of 1934

      Exhibit: 31.2   Certification of Chief Financial Officer, pursuant to Rule
                      13a-14(c) under the Securities Exchange Act of 1934

      Exhibit: 32.1   Certification of Chief Executive Officer, pursuant to
                      18 U.S.C. Section 1350

      Exhibit: 32.2   Certification of Chief Financial Officer, pursuant to
                      18 U.S.C. Section 1350


                                       33

<PAGE>

                                   SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused
this report to be signed on its behalf by the undersigned, thereunto, duly
authorized.

                                   ARGAN, INC.


September 11, 2006                 By: /s/ Rainer Bosselmann
                                       -----------------------------------------
                                       Rainer Bosselmann
                                       Chairman of the Board and
                                       Chief Executive Officer


September 11, 2006                 By: /s/ Arthur F. Trudel
                                       -----------------------------------------
                                       Arthur F. Trudel
                                       Senior Vice President,
                                       Chief Financial Officer and Secretary


                                       34